LOGICA Trademark

Trademark Overview


On Friday, April 22, 2022, a trademark application was filed for LOGICA with the United States Patent and Trademark Office. The USPTO has given the LOGICA trademark a serial number of 97376850. The federal status of this trademark filing is REGISTERED as of Tuesday, September 19, 2023. This trademark is owned by Charles River Laboratories, Inc.. The LOGICA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds...
logica

General Information


Serial Number97376850
Word MarkLOGICA
Filing DateFriday, April 22, 2022
Status700 - REGISTERED
Status DateTuesday, September 19, 2023
Registration Number7171333
Registration DateTuesday, September 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Pseudo MarkLOGICAL
Translation of Words in MarkThe English translation of "LOGICA" in the mark is LOGIC.
Goods and ServicesPharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using machine learning; Pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical lead series or lead compounds via software using artificial intelligence, machine learning, computational modeling, DNA-encoded library screening platform, high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and/or non-GLP safety testing

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code042
First Use Anywhere DateWednesday, April 27, 2022
First Use In Commerce DateWednesday, April 27, 2022

Trademark Owner History


Party NameValo Health, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameCharles River Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Party NameValo Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameCharles River Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Party NameValo Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameCharles River Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Trademark Events


Event DateEvent Description
Tuesday, September 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 19, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, August 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 21, 2023USE AMENDMENT FILED
Tuesday, July 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 21, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 6, 2022NON-FINAL ACTION E-MAILED
Thursday, October 6, 2022NON-FINAL ACTION WRITTEN
Friday, September 23, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 26, 2022NEW APPLICATION ENTERED